cordycepin has been researched along with deoxycytidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aran, JM; Plagemann, PG; Woffendin, C; Wohlhueter, RM | 1 |
Jefferies, MW; King, RW; Zecher, M | 1 |
Hong, DF; Hu, ZM; Huang, DS; Shang, MJ; Wu, WD; Zhang, CW; Zhao, DJ | 1 |
3 other study(ies) available for cordycepin and deoxycytidine
Article | Year |
---|---|
Mobility of nucleoside transporter of human erythrocytes differs greatly when loaded with different nucleosides.
Topics: 2-Chloroadenosine; Cytidine; Deoxyadenosines; Deoxycytidine; Erythrocytes; Humans; Kinetics; Nucleosides; Substrate Specificity | 1990 |
Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine.
Topics: Antiviral Agents; Cell Line; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; Deoxyuridine; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Genes, Reporter; HeLa Cells; Hepacivirus; Hepatocytes; Humans; Interferon-alpha; Interferon-beta; Kidney; Luciferases; Recombinant Fusion Proteins; Ribavirin; RNA, Viral; Templates, Genetic; Virus Replication | 2002 |
Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Deoxyadenosines; Deoxycytidine; Drug Resistance, Neoplasm; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |